Medtronic plc (MDT) P/E Ratio History
Historical price-to-earnings valuation from 1991 to 2026
Loading P/E history...
MDT Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Medtronic plc (MDT) trades at a price-to-earnings ratio of 21.5x, with a stock price of $77.60 and trailing twelve-month earnings per share of $3.58.
The current P/E is 27% below its 5-year average of 29.6x. Over the past five years, MDT's P/E has ranged from a low of 22.6x to a high of 49.2x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, MDT is roughly in line with its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, MDT trades roughly in line with the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MDT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
MDT P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $150B | 11.3Lowest | 0.38Best | +134% | |
| $83B | 28.9 | - | +55% | |
| $48B | 45.5 | 6.42 | -74% | |
| $112B | 34.8 | 2.34 | +8% | |
| $16B | 23.3 | - | -20% | |
| $52B | 24.8 | 1.50 | -1% | |
| $160B | 57.4 | 2.64 | +23% | |
| $12B | 22.8 | 0.73 | +423%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
MDT Historical P/E Data (1991–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | Fri Jan 23 2026 00:00:00 GM | $100.88 | $3.59 | 28.1x | -10% |
| FY2026 Q2 | Fri Oct 24 2025 00:00:00 GM | $93.67 | $3.71 | 25.2x | -19% |
| FY2026 Q1 | Fri Jul 25 2025 00:00:00 GM | $92.94 | $3.63 | 25.6x | -18% |
| FY2025 Q4 | Wed Apr 30 2025 00:00:00 GM | $84.76 | $3.62 | 23.4x | -25% |
| FY2025 Q3 | Fri Jan 24 2025 00:00:00 GM | $90.19 | $3.29 | 27.4x | -12% |
| FY2025 Q2 | Fri Oct 25 2024 00:00:00 GM | $90.59 | $3.27 | 27.7x | -11% |
| FY2025 Q1 | Fri Jul 26 2024 00:00:00 GM | $78.70 | $2.96 | 26.6x | -15% |
| FY2024 Q4 | $80.24 | $2.75 | 29.2x | -7% | |
| FY2024 Q3 | Fri Jan 26 2024 00:00:00 GM | $86.54 | $3.14 | 27.6x | -12% |
| FY2024 Q2 | Fri Oct 27 2023 00:00:00 GM | $69.43 | $3.07 | 22.6x | -28% |
| FY2024 Q1 | Fri Jul 28 2023 00:00:00 GM | $88.25 | $2.71 | 32.6x | +4% |
| FY2023 Q4 | Sun Apr 30 2023 00:00:00 GM | $90.95 | $2.82 | 32.3x | +3% |
Average P/E for displayed period: 31.3x
Full MDT Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See MDT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MDT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MDT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMDT — Frequently Asked Questions
Quick answers to the most common questions about buying MDT stock.
Is MDT stock overvalued or undervalued?
MDT trades at 21.5x P/E, below its 5-year average of 29.6x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does MDT's valuation compare to peers?
Medtronic plc P/E of 21.5x compares to sector median of 22.1x. The discount suggests lower growth expectations or higher risk.
What is MDT's PEG ratio?
MDT PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1991-2026.